Legal: OrbusNeich takes Boston Scientific patent row to Germany, the Netherlands

February 21, 2013 by Arezu Sarvestani

OrbusNeich files patent infringement lawsuits in Germany and the Netherlands against rival stent-maker Boston Scientific, riding on momentum from a recent win from the European Patent Office.

Orbusneich, Boston Scientific

OrbusNeich is taking a recent patent infringement win against Boston Scientific (NYSE:BSX) even further, filing lawsuits in both Germany and the Netherlands to allege patent infringement over stent technology.

OrbusNeich claims Boston Scientific's Promus Element, Promus Element Plus, Taxus and other stents are infringing on a pair of patents, for which OrbusNeich is seeking a preliminary injunction, damages and a recall of the infringing products that have not been used in patients.

Sign up to get our free newsletters delivered right to your inbox.

OrbusNeich named in its complaint 2 allegedly infringed patents, including the so-called "482" patent that was also at the center of a European infringement battle that ended in OrbusNeich's favor.

Earlier this month the European Patent Office denied a bid by Boston Scientific and its Japanese ally Terumo Corp.(TYO:4543) to have the "'482" patent overturned.